News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER-TLC announces public comment period for upcoming clinical trial
Patients, caregivers, and researchers will have 2 weeks to provide input on plans to test whether glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can help improve Long COVID symptoms.
Announcement
162 Results
162 Results
RECOVER Research Update: November 2024
Recent findings from across RECOVER’s five research areas could improve our ability to identify people with Long COVID, understand the underlying causes of their symptoms, and provide them with care and treatment.
Research Update
R3 Seminar Recap: Patterns of PASC with Initial COVID-19 Infections and Reinfections: EHR Insights
During the October 29th RECOVER Research Review (R3) Seminar, researchers highlighted patterns in electronic health record (EHR) data in patients who developed Long COVID after a first, or subsequent COVID-19 reinfection. By reviewing patient medical records from as early as March 2020, the findings from these studies provide insights into potential risks associated with developing Long COVID.
R3 Seminar Recap
NIH to share RECOVER-TLC updates during November 21 webinar
NIH leaders will discuss the current status of RECOVER-TLC, share information about potential Long COVID treatments to be tested in RECOVER-TLC clinical trials, and answer questions from the public.
Announcement
NIH invites public participation to inform future Long COVID clinical trials
RECOVER-TLC invites the Long COVID community to submit ideas for potential Long COVID treatments and biomarkers, volunteers for working groups, and provide feedback on the next phase of Long COVID clinical trials.
Feature
R3 Seminar Recap: Advancing Long COVID Research by Fostering Collaboration between RECOVER and the All of Us Research Program
During the October 8th RECOVER Research Review (R3) Seminar, researchers described how RECOVER and the All of Us Research Program collaborate to advance our understanding of Long COVID. These different National Institutes of Health (NIH) initiatives are sharing health data and developing innovative tools to gain important insights from that data.
R3 Seminar Recap
RECOVER-ENERGIZE enrolls first clinical trial participant
A research team at RECOVER’s South Dakota study site prioritizes diversity and accessibility in clinical trial enrollment.
Feature
Long COVID clinic provides access to research studies and care for University of New Mexico patients
RECOVER researchers at the University of New Mexico study site have built connections between RECOVER studies and the university’s Long COVID clinic to ensure patients have access to resources and care.
Feature
Use of metformin in adults with diabetes linked to lower risk of Long COVID
Findings from this RECOVER study could inform future efforts to prevent Long COVID using repurposed prescription drugs.
News Release